Selecta Biosciences, Inc. logo

Selecta Biosciences, Inc.

NASDAQ:SELB

Overview | Financials
Company Name Selecta Biosciences, Inc.
Symbol SELB
Currency USD
Price 0.881
Market Cap 135,200,754
Dividend Yield 0%
52-week-range 0.785 - 1.99
Industry Biotechnology
Sector Healthcare
CEO Dr. Carsten Brunn Ph.D.
Website https://selectabio.com

An error occurred while fetching data.

About Selecta Biosciences, Inc.

Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. It is also developing

Related Stocks

CytomX Therapeutics, Inc. logo

CytomX Therapeutics, Inc.

CTMX

1.19 USD

Achilles Therapeutics plc logo

Achilles Therapeutics plc

ACHL

0.71 USD

Rezolute, Inc. logo

Rezolute, Inc.

RZLT

4.87 USD

Greenwich LifeSciences, Inc. logo

Greenwich LifeSciences, Inc.

GLSI

14.17 USD

Anixa Biosciences, Inc. logo

Anixa Biosciences, Inc.

ANIX

3.45 USD

Financials

Numbers are in millions USD

Numbers are in millions USD